Ankyra

Boston, United States

Ankyra is a biotech company developing anchored immunotherapy for cancer treatments.

$45.0M raised

Nov 2021

Series B

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Ankyra raised?

Ankyra has raised $45.0M in total funding. The most recent round was Series B. The last funding was announced in November 2021.

Who are Ankyra's investors?

Ankyra's investors include Sands Capital Ventures, Polaris Partners, Fidelity, Mithril Capital Management, Spring Mountain Capital.

Where is Ankyra headquartered?

Ankyra is headquartered in Boston, United States.

What does Ankyra do?

Ankyra is a biotech company developing anchored immunotherapy for cancer treatments.

What stage is Ankyra at?

Ankyra is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 12, 2021.

MLA

"Ankyra — Funding & Investors." VCBacked, November 12, 2021, https://www.vcbacked.co/company/ankyra. Accessed July 2, 2026.

APA

VCBacked. (2021). Ankyra — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/ankyra

Wikipedia (cite web)

{{cite web |title=Ankyra — Funding & Investors |url=https://www.vcbacked.co/company/ankyra |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 12, 2021.